An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration

Ítems similars

• An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
  per: D’Arcy, Deirdre M, et al.
  Publicat: (2012)
• A pharmacokinetic basis for improving therapeutic outcomes of aminoglycoside therapy during continuous venovenous haemodiafiltration
  per: Spooner, A, et al.
  Publicat: (2007)
• Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
  per: Roger, C, et al.
  Publicat: (2015)
• The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
  per: Toft, Palle, et al.
  Publicat: (1999)
• Early veno-venous haemodiafiltration for sepsis-related multiple organ failure
  per: Page, Bernard, et al.
  Publicat: (2005)